02327.HK
Meilleure Health International Industry Group Limited
HKSE · Industrials · Conglomerates · HK
HKD 0.24
−0.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 221.7M | 36.5M | 50.7M | 129.3M | 119.9M |
| Cost of Revenue | 157.1M | 13.9M | 21.8M | 51.2M | 53.1M |
| Gross Profit | 64.6M | 22.6M | 28.9M | 78.1M | 66.8M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 64.6M | 31.2M | 31.6M | 39.3M | 35.7M |
| General & Admin Expense | 41.1M | 27.6M | 24.6M | 24.5M | 29.7M |
| Selling & Marketing Expense | 5.8M | 3.6M | 7.0M | 14.9M | 6.0M |
| Other Expenses | 460.0K | 1.2M | 204.0K | 15.8M | (2.6M) |
| Total Operating Expenses | 65.1M | 32.3M | 31.8M | 55.1M | 33.1M |
| Cost and Expenses | 223.2M | 46.2M | 54.5M | 106.3M | 86.2M |
| Operating Income (EBIT) | (34.0K) | (9.7M) | (3.9M) | 39.4M | 32.2M |
| Non-Operating | |||||
| Interest Income | — | 29.3M | 22.0M | 18.8M | 26.9M |
| Interest Expense | 17.8M | 9.3M | 10.3M | 11.4M | 11.4M |
| Net Interest Income | (17.8M) | 20.0M | 11.8M | 7.4M | 15.5M |
| Other Non-Op Income/Expense | 99.4M | 40.2M | 49.3M | 13.6M | (6.9M) |
| Non-Operating Income (excl Interest) | — | — | (53.9M) | (25.0M) | — |
| EBT (Pre-Tax Income) | 99.4M | 30.5M | 45.4M | 53.0M | 25.4M |
| Income Tax Expense | 7.3M | 7.5M | 13.4M | 14.5M | 7.6M |
| Bottom Line | |||||
| Net Income | 90.3M | 38.0M | 32.5M | 40.8M | 17.8M |
| Earnings from Cont. Ops | 90.1M | 38.0M | 32.0M | 38.5M | 17.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 90.3M | 38.0M | 32.5M | 40.8M | 17.8M |
| Per Share | |||||
| Basic EPS | HK$0.02 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.00 |
| Diluted EPS | HK$0.02 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.00 |
| Revenue Per Share | HK$0.05 | HK$0.01 | HK$0.01 | HK$0.03 | HK$0.03 |
| Shares | |||||
| Basic Shares Outstanding | 4.1B | 4.1B | 4.1B | 4.1B | 4.1B |
| Diluted Shares Outstanding | 4.1B | 4.1B | 4.1B | 4.1B | 4.1B |
| Profitability Metrics | |||||
| EBITDA | 42.2M | (9.0M) | 56.5M | 71.4M | 55.5M |
| D&A | 737.0K | 737.0K | 1.6M | 2.6M | 3.9M |
| EBIT | 41.5M | (9.7M) | 54.9M | 68.7M | 30.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026